Calum Robb: A Simplified Flow Cytometry Method for Measuring Human NETs
Calum Robb, Senior Key Account Manager at Thermo Fisher Scientific shared a post on LinkedIn about a recent article he and his colleagues co-authored:
“Proud to share our latest publication!
In this study, we developed a robust, flow cytometry–based assay to accurately quantify neutrophil extracellular traps (NETs), a key driver of inflammation in diseases ranging from autoimmunity to sepsis and cancer.
By using dual detection of DNA–Histone complexes, our method reliably distinguishes true NETosis from activation, apoptosis & necrosis, addressing a major challenge in the field.
- Sensitive
- Reproducible
- Scalable for routine lab use
We hope this provides a practical tool to advance NETosis research and support translational studies in inflammatory disease.
Massive thanks to all involved!”
Title: Simplified flow cytometric quantification of human neutrophil extracellular traps (NETs)
Authors: G. Rinaldi, K. K. W. Cheng, C. McCann, F. Rossi, M. Rodriguez-Rios, K. Dhaliwal, A. Bebes, L. Duncan, R. Yuecel, Adriano G. Rossi, Calum T. Robb
Read the Full Article on Journal of Inflammation
Stay updated with Hemostasis Today.
-
Jun 21, 2026, 19:19Tribikram Panda: Ensuring Global Equity in Management of Sickle Cell Disease
-
Jun 21, 2026, 19:15Vicken Babikian Receives Mkhitar Heratsi Medal – AAHPO
-
Jun 21, 2026, 19:11Joaqim Meireles-Brandao: Once Disease is Established, All That Remains is to Mitigate the Consequences
-
Jun 21, 2026, 18:54A Comprehensive Review of Hemophilia A and B – Journal of Thrombosis and Haemostasis
-
Jun 21, 2026, 18:54Maxime Dely: Raising Awareness and Improving Diagnosis of Sickle Cell Disease in France
-
Jun 21, 2026, 18:08Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
-
Jun 21, 2026, 17:59Fakhrul Abedin Jon: Exploring Types of Brain Bleeding
-
Jun 21, 2026, 17:00Jeffrey Schnur: Advanced Treatment Strategies for Deep Vein Thrombosis and Pulmonary Embolism
-
Jun 21, 2026, 16:53Matteo Foschi: When Should We Restart Anticoagulation After a Breakthrough Ischemic Stroke?